TCU’s Cannon Diagnosed with Non-Hodgkin’s Lymphoma

According to multiple reports, former TCU offensive tackle Marcus Gannon will begin chemotherapy at a Fort Worth hospital on Thursday for a form of non-Hodgkin’s lymphoma. Cannon, of course, had been deemed a potential first or second round pick in the upcoming 2011 NFL Draft, and was considered to be one of the premiere talents available at his position.

While murmurs that all was not well with Cannon’s health had been circulating amongst teams, it’s difficult to say how many really knew that he was dealing with this particular condition. Either way, it’s all but guaranteed at this point that the TCU product will drop in the draft -- the question now being how much.

Apparently, the tumor was first detected in Cannon’s abdomen in 2006. However, testing on it showed that it was benign. Later, in 2008, further testing on it still returned negative.

Finally, after the mass grew during the NFL Scouting Combine in February, rumors began to circulate that Cannon was battling testicular cancer. Ultimately, that rumor was proven to be incorrect.

In an effort to keep teams fully apprised of the situation, each NFL team was sent full biopsy results to prove that Cannon was not suffering from testicular cancer. The tests, however, did show that he was suffering from the aforementioned non-Hodgkin’s lymphoma.

Cannon’s four treatments are set to conclude on June 29.

lymphoma roundup

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...